Development of a Clinical Prediction Rule for Risk Stratification of Recurrent Venous Thromboembolism in Patients With Cancer-Associated Venous Thromboembolism
- Resource Type
- Article
- Authors
- Louzada, Martha L.; Carrier, Marc; Lazo-Langner, Alejandro; Dao, Vi; Kovacs, Michael J.; Ramsay, Timothy O.; Rodger, Marc A.; Zhang, Jerry; Lee, Agnes Y.Y.; Meyer, Guy; Wells, Philip S.
- Source
- Circulation (Ovid); July 2012, Vol. 126 Issue: 4 p448-454, 7p
- Subject
- Language
- ISSN
- 00097322; 15244539
Long-term low-molecular-weight heparin (LMWH) is the current standard for treatment of venous thromboembolism (VTE) in cancer patients. Whether treatment strategies should vary according to individual risk of VTE recurrence remains unknown. We performed a retrospective cohort study and a validation study in patients with cancer-associated VTE to derive a clinical prediction rule that stratifies VTE recurrence risk.